For Immediate Release

Bayer Launches hydraSense® Drug-free Children's Nasal Care Line in U.S.

hydraSense® delivers the hydrating power of the sea to gently soothe dry and uncomfortable nasal passages

WHIPPANY, N.J., Nov. 1, 2017 /PRNewswire/ -- Being a parent comes with many surprises — including how often there's a need to comfort a child's dry and uncomfortable nasal passages. The nose requires a certain level of moisture to stay healthy. Hot, dry climates, low humidity, as well as air conditioning, can all lead to dryness in the nose, which can be tough on infants and children. The makers of hydraSense® are pleased to introduce the hydraSense® daily nasal care line to the U.S. market, offering soothing, drug-free saline nasal care solutions for infants and children six months of age and older.

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. (PRNewsfoto/Bayer Corporation)

hydraSense® hydrates and soothes dry and uncomfortable nasal passages and can be used along with oral cold or allergy OTC medications. The drug-free children's daily nasal care line consists of preservative free, ready-to-use products including hydraSense® Ultra-Gentle Nasal Mist, hydraSense® Nasal Care Single-Use Vials and hydraSenseTM Soft Comfort Tip Nasal Aspirator. While most brands of saline nasal care are made from purified water and sodium chloride, hydraSense® saline solution is made with mineral-rich, 100% naturally sourced seawater from the Bay of Saint-Malo, France, whose powerful tides constantly renew the seawater's composition. Now, parents everywhere can take care of their children's nasal care needs and "Sea. The Difference." with hydraSense®.  

"We recognize that more and more parents are searching for drug-free remedies to address their children's delicate nasal passages. The hydraSense® children's daily nasal care line provides a portfolio of gentle drug-free products for parents to sooth their child's nasal passages, with ingredients that are naturally sourced," said Dr. André Schmidt, V.P. U.S. Medical Affairs at Bayer Consumer Health.  "We're pleased to invite parents across the U.S. to discover the benefits of hydraSense® in soothing the discomfort and nasal dryness of their families."

Parents can visit for more information about the hydraSense® drug-free daily nasal care line. hydraSense® can only be purchased at local Walgreens stores or The hydraSense® children's products can be found in the Children's Medicine aisle.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to


Bayer Corporation

Christopher Loder
Vice President, Head of External Communications, U.S.
1-862-404-7437 (office)
1-201-396-4325 (mobile)      

Marina Maher Communications

Noelle Carnevale
212-485-6285 (office)

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.